| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 9 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 14 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 29 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 36 | | | |
| | | | | 38 | | | |
| | | | | 38 | | | |
| | | | | 38 | | | |
| | | | | 39 | | | |
| | | | | 39 | | | |
| | | | | A-1 | | |
Name
|
| |
Year
Initially Elected |
| |
Age(1)
|
| |
Position(s)
|
| |
Expiration of
Term |
| |
Class
|
|
Dov A. Goldstein, M.D.(2)
|
| |
2019
|
| |
55
|
| | Chairperson | | |
2024
|
| |
I
|
|
Gerald J. McDougall(3)(4)
|
| |
2021
|
| |
56
|
| | Director | | |
2025
|
| |
II
|
|
Franklyn G. Prendergast, M.D., Ph.D.(2)(4)
|
| |
2019
|
| |
78
|
| | Director | | |
2023
|
| |
III
|
|
Eric I. Richman(2)(3)(4)
|
| |
2019
|
| |
62
|
| | Director | | |
2024
|
| |
I
|
|
Dietrich A. Stephan, Ph.D.
|
| |
2019
|
| |
53
|
| | Chief Executive Officer and Director | | |
2025
|
| |
II
|
|
Gender
|
| |
Female
|
| |
Male
|
| ||||||
Number of Directors based on gender identity
|
| | | | 0 | | | | | | 5 | | |
Number of Directors Who Self-Identify In any Category Below | | | | | | | | | | | | | |
African American or Black
|
| | | | 0 | | | | | | 0 | | |
Hispanic or Latinx
|
| | | | 0 | | | | | | 0 | | |
White or Caucasian
|
| | | | 0 | | | | | | 4 | | |
Asian
|
| | | | 0 | | | | | | 0 | | |
LGBQT+
|
| | | | 0 | | | | | | 0 | | |
Information not provided
|
| | | | 0 | | | | | | 1 | | |
Gender
|
| |
Female
|
| |
Male
|
| ||||||
Number of Directors based on gender identity
|
| | | | 0 | | | | | | 6 | | |
Number of Directors Who Self-Identify In any Category Below | | | | | | | | | | | | | |
African American or Black
|
| | | | 0 | | | | | | 0 | | |
Hispanic or Latinx
|
| | | | 0 | | | | | | 0 | | |
White or Caucasian
|
| | | | 0 | | | | | | 5 | | |
Asian
|
| | | | 0 | | | | | | 0 | | |
LGBQT+
|
| | | | 0 | | | | | | 0 | | |
Information not provided
|
| | | | 0 | | | | | | 1 | | |
| | |
2022
|
| |
2021
|
| ||||||
Audit Fees(1):
|
| | | $ | 322,650 | | | | | $ | 272,950 | | |
Audit-Related Fees(2):
|
| | | | — | | | | | | — | | |
Tax Fees(3):
|
| | | | — | | | | | | — | | |
All Other Fees(4):
|
| | | | — | | | | | | — | | |
Total All Fees:
|
| | | $ | 322,650 | | | | | $ | 272,950 | | |
Name
|
| |
Age
|
| |
Position
|
|
Dietrich A. Stephan, Ph.D.
|
| |
53
|
| | Chief Executive Officer and Director | |
Todd P. Branning
|
| |
53
|
| | Chief Financial Officer and Secretary | |
Name and Position
|
| |
Year
|
| |
Salary
|
| |
Bonus(1)
|
| |
Stock
Awards |
| |
Option
Awards(2) |
| |
Non-Equity
Incentive Plan Compensation |
| |
All Other
Compensation(3) |
| |
Total
|
| ||||||||||||||||||||||||
Dietrich A. Stephan,
Chief Executive Officer |
| | | | 2022 | | | | | $ | 536,798 | | | | | $ | 247,000 | | | | | $ | — | | | | | $ | 318,240 | | | | | $ | — | | | | | $ | 52,782 | | | | | $ | 1,154,820 | | |
| | | 2021 | | | | | $ | 469,149 | | | | | $ | 196,875 | | | | | $ | — | | | | | $ | 799,886 | | | | | $ | — | | | | | $ | 47,808 | | | | | $ | 1,513,718 | | | ||
Todd P. Branning,
Chief Financial Officer |
| | | | 2022 | | | | | $ | 310,577 | | | | | $ | — | | | | | $ | — | | | | | $ | 495,000 | | | | | $ | — | | | | | $ | 13,446 | | | | | $ | 819,023 | | |
| | | 2021 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | ||
William R. Mann, Ph.D.,
Former President and Chief Operating Officer(4) |
| | | | 2022 | | | | | $ | 422,221 | | | | | $ | 168,000 | | | | | $ | — | | | | | $ | 62,587 | | | | | $ | — | | | | | $ | 30,111 | | | | | $ | 682,919 | | |
| | | 2021 | | | | | $ | 381,923 | | | | | $ | 62,500 | | | | | $ | — | | | | | $ | 61,750 | | | | | $ | — | | | | | $ | 25,975 | | | | | $ | 532,148 | | |
Name
|
| |
Year
|
| |
401(k)
Company |
| |
Group Term
|
| |
Health Benefits
|
| |
Life
Insurance |
| |
Paid Time
Off Buy Back |
| |
Total Other
Compensation |
| |||||||||||||||||||||
Dietrich A. Stephan, Ph.D.
Chief Executive Officer |
| | | | 2022 | | | | | $ | 10,694 | | | | | $ | — | | | | | $ | 18,155 | | | | | $ | 23,933 | | | | | | — | | | | | $ | 52,782 | | |
| | | 2021 | | | | | $ | — | | | | | $ | — | | | | | $ | 25,716 | | | | | | 22,092 | | | | | | — | | | | | $ | 47,808 | | | ||
Todd P. Branning
Chief Financial Officer |
| | | | 2022 | | | | | $ | 7,356 | | | | | $ | 439 | | | | | $ | 5,651 | | | | | | — | | | | | | — | | | | | $ | 13,446 | | |
| | | 2021 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | | — | | | | | | — | | | | | $ | — | | | ||
William R. Mann, Ph.D.
Former President and Chief Operating Officer |
| | | | 2022 | | | | | $ | 8,287 | | | | | $ | 684 | | | | | $ | 21,140 | | | | | | — | | | | | | — | | | | | $ | 30,111 | | |
| | | 2021 | | | | | $ | — | | | | | $ | 454 | | | | | | 25,222 | | | | | | — | | | | | | — | | | | | $ | 25,676 | | |
| | |
Option Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
Name
|
| |
Number of
Securities Underlying Unexercised Options Exercisable (#) |
| |
Number of
Securities Underlying Unexercised Options Non- Exercisable (#) |
| |
Equity
Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |
Number of
Shares or Units of Stock That Have Not Vested (#) |
| |
Market
Value of Shares or Units of Stock That Have Not Vested ($) |
| |
Equity
Incentive Plan Awards: Number of Unearned shares, Units or Other Rights That Have Not Vested (#) |
| |
Equity
Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) |
| |||||||||||||||||||||||||||
Dietrich A. Stephan, Ph.D.
|
| | | | 125,984 | | | | | | — | | | | | | — | | | | | $ | 0.022 | | | | | | 12/31/2023(1) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 3,608 | | | | | | 4,638(2) | | | | | | — | | | | | $ | 138.40 | | | | | | 12/29/2030(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | 15,300(3) | | | | | | — | | | | | $ | 31.60 | | | | | | 1/24/2032(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Todd P. Branning
|
| | | | — | | | | | | 15,000(5) | | | | | | — | | | | | $ | 50.40 | | | | | | 1/10/2032(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
William R. Mann, Ph.D.
|
| | | | 4,740 | | | | | | 4,010(6) | | | | | | — | | | | | $ | 149.20 | | | | | | 7/27/2030(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 339 | | | | | | 911(7) | | | | | | — | | | | | $ | 69.80 | | | | | | 8/16/2031(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | 3,009(3) | | | | | | — | | | | | $ | 31.60 | | | | | | 1/24/2032(4) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Fiscal Year
|
| |
Summary
Compensation Table Total for CEO ($)(1) |
| |
Compensation
Actually Paid to CEO ($)(2) |
| |
Average Summary
Compensation Table Total for Non-CEO Named E xecutive Officers (“NEOs”) ($)(3) |
| |
Average
Compensation Actually Paid to Non-CEO NEOs ($)(2)(3) |
| |
Value of Initial
Fixed $100 Investment Based on: Total Shareholder Return ($)(4) |
| |
Net
Income ($ millions) |
| ||||||||||||||||||
2022
|
| | | $ | 1,154,820 | | | | | $ | 650,042 | | | | | $ | 750,971 | | | | | $ | 379,204 | | | | | $ | 5.20 | | | | | $ | (33.78) | | |
2021
|
| | | $ | 1,513,718 | | | | | $ | 997,784 | | | | | $ | 848,982 | | | | | $ | (584,865) | | | | | $ | 47.56 | | | | | $ | (25.41) | | |
Item and Value Added (Deducted)
|
| |
2022
|
| |
2021
|
| ||||||
For CEO: | | | | | | | | | | | | | |
Summary Compensation Table Total
|
| | | $ | 1,154,820 | | | | | $ | 1,513,718 | | |
- Summary Compensation Table “Option Awards” column value
|
| | | | (318,240) | | | | | | (799,886) | | |
+ year-end fair value of outstanding and unvested equity awards granted in the fiscal year
|
| | | | 47,863 | | | | | | 283,952 | | |
+/- change in fair value of outstanding and unvested equity awards granted in prior years
|
| | | | (163,254) | | | | | | 0 | | |
+ vest date fair value of equity awards granted in the covered year
|
| | | | 0 | | | | | | 0 | | |
+/- change in fair value of prior-year equity awards vested in the fiscal year
|
| | | | (71,147) | | | | | | 0 | | |
Compensation Actually Paid
|
| | | $ | 650,042 | | | | | $ | 997,784 | | |
For Non-CEO NEOs (Average): | | | | | | | | | | | | | |
Summary Compensation Table Total
|
| | | $ | 750,971 | | | | | $ | 848,982 | | |
- Summary Compensation Table “Option Awards” column value
|
| | | | (278,794) | | | | | | (350,387) | | |
+ year-end fair value of outstanding and unvested equity awards granted in the fiscal year
|
| | | | 22,790 | | | | | | 29,207 | | |
+/- change in fair value of outstanding and unvested equity awards granted in prior years
|
| | | | (86,743) | | | | | | (216,241) | | |
+ vest date fair value of equity awards granted in the covered year
|
| | | | 0 | | | | | | 0 | | |
+/- change in fair value of prior-year equity awards vested in the fiscal year
|
| | | | (29,020) | | | | | | (896,426) | | |
Compensation Actually Paid
|
| | | $ | 379,204 | | | | | $ | (584,865) | | |
| Total Shareholder Return | |
| Net Income | |
Name
|
| |
Cash
Compensation(1) |
| |
Option Grants(2)
|
| |
Stock Awards(3)
|
| |
Total
|
| ||||||||||||
Dov A. Goldstein, M.D.(4)
|
| | | $ | 58,625 | | | | | $ | 15,792 | | | | | $ | — | | | | | $ | 74,417 | | |
Eric J. Ende, M.D.(5)
|
| | | $ | 28,125 | | | | | $ | 335,792 | | | | | $ | — | | | | | $ | 363,917 | | |
Franklyn G. Prendergast, M.D., Ph.D.(6)
|
| | | $ | 52,500 | | | | | $ | 15,792 | | | | | $ | — | | | | | $ | 68,292 | | |
Eric I. Richman(7)
|
| | | $ | 52,583 | | | | | $ | 15,792 | | | | | $ | — | | | | | $ | 68,375 | | |
Gerald J. McDougall(8)
|
| | | $ | 44,000 | | | | | $ | 15,792 | | | | | $ | — | | | | | $ | 59,792 | | |
Name and Address of Beneficial Owner
|
| |
Number of Shares
Beneficially Owned |
| |
Percentage of
Class (%)(1) |
| ||||||
5% Stockholders | | | | | | | | | | | | | |
Dietrich A. Stephan, Ph.D., Director and Chief Executive Officer(2)
|
| | | | 250,207 | | | | | | 12.0% | | |
Greenlight Capital, Inc.(3)
|
| | | | 136,350 | | | | | | 6.5% | | |
Armistice Capital Master Fund Ltd.(4)
|
| | | | 5,671,052 | | | | | | 75.34% | | |
Other Directors and Named Executive Officers(5) | | | | | | | | | | | | | |
Todd P. Branning, Chief Financial Officer(6)
|
| | | | 4,210 | | | | | | * | | |
Dov A. Goldstein, M.D., Chairperson (7)
|
| | | | 14,879 | | | | | | * | | |
Gerald J. McDougall, Director(8)
|
| | | | 4,153 | | | | | | * | | |
Franklyn G. Prendergast, M.D., Ph.D., Director(9)
|
| | | | 13,379 | | | | | | * | | |
Eric I. Richman, Director(10)
|
| | | | 15,626 | | | | | | * | | |
All current executive officers and directors as a group (six persons)(11)
|
| | | | 302,454 | | | | | | 14.5% | | |